Language:

Results 1 - 20 of 3,559 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Peer-reviewed Journals (3,259)

Result Number	Material Type	Record Details and Options
1	Material Type: Article	The cost-effectiveness of bevacizumab, ranibizumab and aflibercept for the treatment of age-related macular degeneration-A cost-effectiveness analysis from a societal perspective PloS one, 2018-05, Vol.13 (5), p.e0197670-e0197670 [Peer Reviewed Journal] COPYRIGHT 2018 Public Library of Science ;COPYRIGHT 2018 Public Library of Science ;2018 van Asten et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2018 van Asten et al 2018 van Asten et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0197670 ;PMID: 29772018 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Correction: Five-year outcomes of photodynamic therapy combined with intravitreal injection of ranibizumab or aflibercept for polypoidal choroidal vasculopathy PloS one, 2020-03, Vol.15 (3), p.e0230505-e0230505 [Peer Reviewed Journal] COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Kikushima et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Kikushima et al 2020 Kikushima et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0230505 ;PMID: 32160267 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	Efficacy and Safety of a Proposed Ranibizumab Biosimilar Product vs a Reference Ranibizumab Product for Patients With Neovascular Age-Related Macular Degeneration: A Randomized Clinical Trial Archives of ophthalmology (1960), 2021-01, Vol.139 (1), p.68 [Peer Reviewed Journal] Copyright American Medical Association Jan 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.5053 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration Cochrane database of systematic reviews, 2020-05, Vol.2020 (5), p.CD012208 [Peer Reviewed Journal] Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012208.pub2 ;PMID: 32374423 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity Cochrane database of systematic reviews, 2018-01, Vol.2018 (1), p.CD009734 [Peer Reviewed Journal] Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD009734.pub3 ;PMID: 29308602 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Anti-vascular endothelial growth factor treatment for retinal conditions: a systematic review and meta-analysis BMJ open, 2019-05, Vol.9 (5), p.e022031-e022031 [Peer Reviewed Journal] Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2019 Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2019 ;ISSN: 2044-6055 ;EISSN: 2044-6055 ;DOI: 10.1136/bmjopen-2018-022031 ;PMID: 31142516 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis Cochrane database of systematic reviews, 2018-10, Vol.2018 (10), p.CD007419 [Peer Reviewed Journal] Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007419.pub6 ;PMID: 30325017 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial The Lancet (British edition), 2019-10, Vol.394 (10208), p.1551-1559 [Peer Reviewed Journal] 2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31344-3 ;PMID: 31522845 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Ranibizumab and Aflibercept: Intraocular Pharmacokinetics and Their Effects on Aqueous VEGF Level in Vitrectomized and Nonvitrectomized Macaque Eyes Investigative ophthalmology & visual science, 2015-10, Vol.56 (11), p.6501-6505 [Peer Reviewed Journal] ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.15-17279 ;PMID: 26447985 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion Medicine (Baltimore), 2020-05, Vol.99 (21), p.e20222 [Peer Reviewed Journal] Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000020222 ;PMID: 32481293 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	Material Type: Article	Biosimilars for Retinal Diseases: An Update American journal of ophthalmology, 2021-04, Vol.224, p.36-42 [Peer Reviewed Journal] 2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.11.017 ;PMID: 33309691 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	Combination of Grid Laser Photocoagulation and a Single Intravitreal Ranibizumab as an Efficient and Cost-Effective Treatment Option for Macular Edema Secondary to Branch Retinal Vein Occlusion Rejuvenation research, 2019-08, Vol.22 (4), p.335-341 [Peer Reviewed Journal] 2019, Mary Ann Liebert, Inc., publishers ;ISSN: 1549-1684 ;EISSN: 1557-8577 ;DOI: 10.1089/rej.2018.2141 ;PMID: 30444191 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Anti‐vascular endothelial growth factor for neovascular age‐related macular degeneration Cochrane database of systematic reviews, 2019-03, Vol.2019 (3), p.CD005139 [Peer Reviewed Journal] Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD005139.pub4 ;PMID: 30834517 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Real-world effectiveness and safety of ranibizumab for the treatment of myopic choroidal neovascularization: Results from the LUMINOUS study PloS one, 2020-01, Vol.15 (1), p.e0227557-e0227557 [Peer Reviewed Journal] COPYRIGHT 2020 Public Library of Science ;COPYRIGHT 2020 Public Library of Science ;2020 Hamilton et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020 Hamilton et al 2020 Hamilton et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0227557 ;PMID: 31961888 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Evaluation of Fluorophotometry to Assess the Vitreal Pharmacokinetics of Protein Therapeutics Investigative ophthalmology & visual science, 2015-10, Vol.56 (11), p.6991-6999 [Peer Reviewed Journal] ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.15-17457 ;PMID: 26513505 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	Material Type: Article	Ranibizumab for exudative age-related macular degeneration: A five year study of adherence to follow-up in a real-life setting Journal francais d'ophtalmologie, 2015-09, Vol.38 (7), p.620-627 [Peer Reviewed Journal] 2015 ;Copyright © 2015. Published by Elsevier Masson SAS. ;ISSN: 0181-5512 ;EISSN: 1773-0597 ;DOI: 10.1016/j.jfo.2014.11.015 ;PMID: 25913443 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study PloS one, 2016-05, Vol.11 (5), p.e0153052-e0153052 [Peer Reviewed Journal] COPYRIGHT 2016 Public Library of Science ;COPYRIGHT 2016 Public Library of Science ;2016 Schauwvlieghe et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2016 Schauwvlieghe et al 2016 Schauwvlieghe et al ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0153052 ;PMID: 27203434 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Comparative Study of Oct Angiographic Finding in Diabetic Macular Edema After Intravitreal Triamicinilone Acetonide Injection and Intravitreal Ranibizumab Injection International journal of medical arts, 2022-10, Vol.4 (10), p.2741-2748 [Peer Reviewed Journal] ISSN: 2682-3780 ;ISSN: 2636-4174 ;EISSN: 2682-3780 ;DOI: 10.21608/ijma.2023.176143.1559 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN) Health technology assessment (Winchester, England), 2015-10, Vol.19 (78), p.1-298 [Peer Reviewed Journal] ISSN: 1366-5278 ;EISSN: 2046-4924 ;DOI: 10.3310/hta19780 ;PMID: 26445075 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	Advances in the treatment of diabetic retinopathy Journal of diabetes and its complications, 2019-12, Vol.33 (12), p.107417, Article 107417 [Peer Reviewed Journal] 2019 ;Copyright © 2019. Published by Elsevier Inc. ;Copyright Elsevier Limited Dec 2019 ;ISSN: 1056-8727 ;EISSN: 1873-460X ;DOI: 10.1016/j.jdiacomp.2019.107417 ;PMID: 31669065 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by

Results 1 - 20 of 3,559 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Personalize your results

Edit

Add page to My Research

Refine Search Results

Expand My Results

Expand My Results

Show only

Peer-reviewed Journals (3,259)

on this subject:


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Results 1 - 20 of 3,559 for All Library Resources

Copyright American Medical Association Jan 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.5053

Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD012208.pub2 ;PMID: 32374423

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD009734.pub3 ;PMID: 29308602

Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD007419.pub6 ;PMID: 30325017

2019 Elsevier Ltd ;Copyright © 2019 Elsevier Ltd. All rights reserved. ;2019. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(19)31344-3 ;PMID: 31522845

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.15-17279 ;PMID: 26447985

Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. 2020 ;ISSN: 0025-7974 ;EISSN: 1536-5964 ;DOI: 10.1097/MD.0000000000020222 ;PMID: 32481293

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2020.11.017 ;PMID: 33309691

2019, Mary Ann Liebert, Inc., publishers ;ISSN: 1549-1684 ;EISSN: 1557-8577 ;DOI: 10.1089/rej.2018.2141 ;PMID: 30444191

Copyright © 2019 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. ;EISSN: 1465-1858 ;EISSN: 1469-493X ;DOI: 10.1002/14651858.CD005139.pub4 ;PMID: 30834517

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.15-17457 ;PMID: 26513505

2015 ;Copyright © 2015. Published by Elsevier Masson SAS. ;ISSN: 0181-5512 ;EISSN: 1773-0597 ;DOI: 10.1016/j.jfo.2014.11.015 ;PMID: 25913443

ISSN: 2682-3780 ;ISSN: 2636-4174 ;EISSN: 2682-3780 ;DOI: 10.21608/ijma.2023.176143.1559

ISSN: 1366-5278 ;EISSN: 2046-4924 ;DOI: 10.3310/hta19780 ;PMID: 26445075

2019 ;Copyright © 2019. Published by Elsevier Inc. ;Copyright Elsevier Limited Dec 2019 ;ISSN: 1056-8727 ;EISSN: 1873-460X ;DOI: 10.1016/j.jdiacomp.2019.107417 ;PMID: 31669065

Results 1 - 20 of 3,559 for All Library Resources

Personalize your results

Refine Search Results

Expand My Results

Show only

Refine My Results

Creation Date

New Records

Resource Type

Subject

Databases

Language

Journal Title

on this subject:

Searching Remote Databases, Please Wait